agilon health, inc.
AGL
$2.97
$0.082.77%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 299.74% | 54.09% | -274.14% | -- | -137.85% |
| Total Depreciation and Amortization | 17.66% | 37.15% | 52.59% | -- | 39.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -177.20% | -85.56% | 43.12% | -- | 51.02% |
| Change in Net Operating Assets | 38.75% | 10.61% | 1,370.18% | -- | 30.76% |
| Cash from Operations | 33.05% | 126.84% | 40.83% | 11.73% | 21.44% |
| Capital Expenditure | -22.62% | 16.94% | 13.53% | -- | 15.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -135.25% | 8,618.12% | 832.95% | -- | 2,099.16% |
| Cash from Investing | -144.89% | 1,174.58% | 522.00% | -9.06% | 201.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | -- | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -81.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -128.80% | 97.40% | -199.72% | 99.15% | -93.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,408.62% | 162.40% | 265.42% | 98.91% | 104.09% |